规格: | 98% |
分子量: | 363.5 |
包装 | 价格(元) |
50ug | 电议 |
100ug | 电议 |
Background:
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9(11β-13,14-dihydro-15-keto PGF2α-d9) is intended for use as an internal standard for the quantification of 11β-13,14-dihydro-15-keto PGF2αby GC- or LC-MS. 11β-13,14-dihydro-15-keto PGF2αis a metabolite of prostaglandin D2in the 15-hydroxy PGDH pathway.1,2Infusion or inhalation of tritiated PGD2in normal males results in the appearance of peak levels of both 11β-PGF2α, as the immediate product, and 11β-13,14-dihydro-15-keto PGF2αin the plasma within 10 minutes.1Homogenates of human lung metabolize PGD2first to 11β-PGF2αand then to 11β-15-keto-PGF2αin the presence of NAD+, but not 11β-13,14-dihydro-15-keto PGF2α.2Guinea pig liver and kidney homogenates metabolize PGD2to 11β-13,14-dihydro-15-keto PGF2α,via11β-PGF2α, in the presence of NAD+and NADP+.2
1.Robinson, C., Hardy, C.C., and Holgate, S.T.The metabolism of prostaglandin D2 after inhalation or intravenous infusion in normal menBiochim. Biophys. Acta963(2)151-161(1988) 2.Robinson, C., Herbert, C.A., Bedwell, S., et al.The metabolism of prostaglandin D2. Evidence for the sequential conversion by NADPH and NAD+ dependent pathwaysBiochem. Pharmacol.38(19)3267-3271(1989)